Empagliflozin+ Metformin in pharma franchise in Jharkhand

Empagliflozin+ Metformin in PCD pharma franchise in Amaravati

Empagliflozin+ Metformin in top pharma company in Varanasi

Empagliflozin+ Metformin in pcd pharma supplier in Srinagar

Empagliflozin+ Metformin in phama franchise company in India
Empagliflozin+ Metformin in phama distributor in Aurangabad

Emplozin M 12.5/500 Tablet

Composition : Empagliflozin (12.5mg) + Metformin (500mg)

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 6x10

Price : ₹1/-

Please Contact For Best Price

Emplozin M 12.5/500 Tablet is a combination of Empagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, and Metformin, a biguanide class antidiabetic drug. This combination works synergistically to help manage Type 2 diabetes mellitus by lowering blood sugar levels. Empagliflozin works by preventing the reabsorption of glucose from the kidneys, increasing glucose excretion through urine. Metformin primarily reduces hepatic glucose production and improves insulin sensitivity, both of which contribute to better control of blood sugar.

This dual-action tablet is used in patients who cannot adequately control their blood sugar levels through diet, exercise, or single-drug therapy alone. It can be prescribed for adult patients with Type 2 diabetes as part of a comprehensive diabetes management plan, often along with diet and exercise.

Read More

About the Product

Emplozin M 12.5/500 Tablet is a combination of Empagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, and Metformin, a biguanide class antidiabetic drug. This combination works synergistically to help manage Type 2 diabetes mellitus by lowering blood sugar levels. Empagliflozin works by preventing the reabsorption of glucose from the kidneys, increasing glucose excretion through urine. Metformin primarily reduces hepatic glucose production and improves insulin sensitivity, both of which contribute to better control of blood sugar.

This dual-action tablet is used in patients who cannot adequately control their blood sugar levels through diet, exercise, or single-drug therapy alone. It can be prescribed for adult patients with Type 2 diabetes as part of a comprehensive diabetes management plan, often along with diet and exercise.

May cause nausea, vomiting, diarrhea, or dehydration; rare cases of lactic acidosis.

For the management of Type 2 diabetes mellitus, used alongside diet and exercise to control blood sugar levels.

Not recommended for patients with severe kidney issues or metabolic acidosis; regular monitoring of kidney function is advised.

Store in a cool, dry place, away from direct sunlight and moisture.

Get in Touch